Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Nov 12, 2021 3:27pm
298 Views
Post# 34121244

Additional Testing

Additional Testing

Hopefully the IRB approval and the securing of test sites will kill two birds with one stone. This additional testing could be carried out to satisfy the requirements for applying for approval for at home testing (as per the NRs) as well as fulfilling the requirements for cross reactivity testing (as expressed in the recent interview with Rob). 

Most companies applied for FDA EUA for the use of their tests in a lab, clinical or health practitioner setting ...and then applied separately for at home use. That is one of the reasons you see the same company with the same test more than once on the FDA EUA list. Any modification to the test or it's method or site of use required a separate application. It appears Rob wants to or is being encouraged to do it all at once ....by the FDA??? That, imho, is an incredibly positive development.

Let's go Therma Bright ....the anticipation is bubbling!

Have a great weekend everyone!!!

<< Previous
Bullboard Posts
Next >>